SYMPLICITY: not all that simple

Slides:



Advertisements
Similar presentations
A.M. Thompson, T.G. Pickering  Kidney International 
Advertisements

Eoin O’Brien, DSc, MD, Eamon Dolan, MD, FRCPI  Clinical Therapeutics 
Beta blockers in the management of chronic kidney disease
Plasma sodium and hypertension
Anemia management in chronic kidney disease
Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure  Steven Fishbane, Nobuyuki Miyawaki  Kidney International 
Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.
C-reactive protein and dialysis access
Volume 93, Issue 1, Pages (January 2018)
Prehypertension and chronic kidney disease: the ox or the plow?
Reassessment of the care of the patient with chronic kidney disease
C-reactive protein and dialysis access
Volume 75, Issue 11, Pages (June 2009)
John P. Middleton, Patrick H. Pun  Kidney International 
Need for better diabetes treatment for improved renal outcome
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
Current and emerging management options for Clostridium difficile infection: what is the role of fidaxomicin?  O.A. Cornely  Clinical Microbiology and.
Volume 76, Issue 3, Pages (August 2009)
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
Volume 74, Issue 3, Pages (August 2008)
Volume 81, Issue 3, Pages (February 2012)
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Nephrology Crosswords: Hemodialysis
Volume 91, Issue 5, Pages (May 2017)
Volume 377, Issue 9771, Pages (March 2011)
David Del Bello, Michael J. Ross, Shirish S. Huprikar 
Nephrology Crossword: History of nephrology
Volume 73, Issue 10, Pages (May 2008)
Blood pressure targets in hemodialysis patients
Volume 75, Issue 11, Pages (June 2009)
Should kidney donors be genotyped for APOL1 risk alleles?
Volume 85, Issue 3, Pages (March 2014)
Volume 87, Issue 1, Pages (January 2015)
Novel phosphate binders: plus ça change, plus c’est la même chose
A physician's perseverance uncovers problems in a key nephrology study
Effects of hemodialysis on cardiac function
Volume 61, Issue 6, Pages (June 2002)
Volume 83, Issue 5, Pages (May 2013)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Alternate-day dialysis may be needed for hemodialysis patients
Nephrology Crossword: Peritoneal Dialysis
Counteracting progression of renal disease: A look into the future
Nephrology Crossword: Glomerulonephritis
Volume 81, Issue 4, Pages (February 2012)
Circadian regulation of renal function
Nina Vasavada, Chandan Saha, Rajiv Agarwal  Kidney International 
A man with a hole in his penis
Volume 87, Issue 5, Pages (May 2015)
Volume 73, Issue 9, Pages (May 2008)
Volume 82, Issue 9, Pages (November 2012)
Volume 64, Issue 2, Pages (August 2003)
Daily nocturnal home hemodialysis
Carmine Zoccali, Francesca Mallamaci  Kidney International 
The course of the remnant kidney model in mice
Volume 83, Issue 5, Pages (May 2013)
The Danish Renal Biopsy Register
Collapsing glomerulopathy: beyond serendipity in mouse genetics
Is it the low-protein diet or simply the salt restriction?
Charles A. Herzog  Kidney International 
Importance of blood pressure control in hemodialysis patient survival
Volume 70, Issue 5, Pages (September 2006)
Volume 75, Issue 7, Pages (April 2009)
The international realities of live donor kidney transplantation
The International Pediatric Peritonitis Registry: Starting to walk
Evaluation of the Losartan in Hemodialysis (ELHE) Study
Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga 
The Ebf1 knockout mouse and glomerular maturation
Antonio Piccoli, Luana Pillon  Kidney International 
Presentation transcript:

SYMPLICITY: not all that simple Friedrich C. Luft  Kidney International  Volume 85, Issue 5, Pages 999-1001 (May 2014) DOI: 10.1038/ki.2014.153 Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 1 SYMPLICITY HTN-3 protocol. Two screening sessions were conducted. All patients underwent angiography and were then randomized to ablation or no ablation. The control group was to have the option to undergo ablation after 6 months. (Adapted from ref. 1.) Abbreviations: ABPM, ambulatory blood pressure monitoring; SBP, systolic blood pressure. Kidney International 2014 85, 999-1001DOI: (10.1038/ki.2014.153) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 2 The end result was a minimal non-significant difference between study patients and controls. (From ref. 5. Copyright 2014 Massachusetts Medical Society. Reprinted with permission from Massachusetts Medical Society.) Kidney International 2014 85, 999-1001DOI: (10.1038/ki.2014.153) Copyright © 2014 International Society of Nephrology Terms and Conditions